Vivanza Biosciences Ltd Q1FY22 consolidated PAT at Rs. 32.18 lakhs

Vivanza Biosciences Ltd has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.0.7096 crores during the period ended June 30, 2021 as compared to Rs.3 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.0.3218 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.(0.1283) crores for the period ended March 31, 2021.

The company has reported EPS of Rs.0.80 for the period ended June 30, 2021 as compared to Rs.(0.32) for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 0.7096 crs	₹ 3 crs	-76.35%
Net Profit	₹ 0.3218 crs	₹ (0.1283) crs	350.82%
EPS	₹ 0.80	₹ (0.32)	350%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.0.7096 crores during the period ended June 30, 2021 as compared to Rs.0.6902 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.0.3218 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.(0.1688) crores for the period ended June 30, 2020.

The company has reported EPS of Rs.0.80 for the period ended June 30, 2021 as compared to Rs.(0.42) for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 0.7096 crs	₹ 0.6902 crs	2.81%
Net Profit	₹ 0.3218 crs	₹ (0.1688) crs	290.64%
EPS	₹ 0.80	₹ (0.42)	290.48%

Shares of Vivanza Biosciences Ltd was last trading in BSE at Rs. 101 as compared to the previous close of Rs. 101. The total number of shares traded during the day was 348 in over 7 trades.

The stock hit an intraday high of Rs. 101 and intraday low of 95.95. The net turnover during the day was Rs. 33936.

Source : Equity Bulls

Keywords